Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy
about
Cardiac progenitor cells for heart repairAntifibrotic therapies to control cardiac fibrosisThe Evolution of the Stem Cell Theory for Heart FailureImproving Cell Engraftment in Cardiac Stem Cell TherapyTranslational research of adult stem cell therapyConcise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart DiseaseProgramming and reprogramming a human heart cellCardiac stem cells: biology and clinical applications"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant resultsCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsOrigin of cardiomyocytes in the adult heartXenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled TrialDeveloping miRNA therapeutics for cardiac repair in ischemic heart diseaseThe Role of MicroRNAs in Cardiac Stem Cellsc-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart.Cardiac stem cell therapy for cardiac repair.SCF increases cardiac stem cell migration through PI3K/AKT and MMP‑2/‑9 signalingA bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.New vessel formation in the context of cardiomyocyte regeneration--the role and importance of an adequate perfusing vasculature.Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment.Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium.Cardiac regeneration using pluripotent stem cells--progression to large animal models.Agonists of growth hormone-releasing hormone stimulate self-renewal of cardiac stem cells and promote their survival."Second-generation" stem cells for cardiac repairDirect evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium.Safety of intracoronary infusion of 20 million C-kit positive human cardiac stem cells in pigs.Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarctionDelayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine.Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial InfarctionGlutamine Regulates Cardiac Progenitor Cell Metabolism and Proliferation.Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.Translational aspects of cardiac cell therapy.S-Nitrosoglutathione Reductase Deficiency Enhances the Proliferative Expansion of Adult Heart Progenitors and Myocytes Post Myocardial InfarctionFinding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytesPreconditioning Human Cardiac Stem Cells with an HO-1 Inducer Exerts Beneficial Effects After Cell Transplantation in the Infarcted Murine HeartLong-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist foPreconditioning c-Kit-positive Human Cardiac Stem Cells with a Nitric Oxide Donor Enhances Cell Survival through Activation of Survival Signaling Pathways.Modeling Doxorubicin-Induced Cardiotoxicity in Human Pluripotent Stem Cell Derived-CardiomyocytesPretreatment of Cardiac Stem Cells With Exosomes Derived From Mesenchymal Stem Cells Enhances Myocardial RepairA Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
P2860
Q26739750-557BCCED-08B2-4171-B971-19FFF05E64D3Q26745841-B1D0A47B-5ACA-4B30-8353-ABC500CEB9A3Q26769042-5CBD14C9-5C22-45BB-8B61-9AB925877586Q26771255-30E390E7-6E9A-4C71-AF90-80B80E367789Q26774565-2C79F34F-FA19-454A-BAD7-194BF22D37D4Q26774781-A76FAB61-0488-4E54-A7C5-C55119C72920Q26823933-BBAE6391-D8E8-4C9F-AEDA-857D8DDA60DFQ26825051-7B029573-F406-4503-93CA-AAB19D866379Q26859990-C4487131-16B1-48D6-A675-C94989893266Q27001159-811DE7C9-0E9B-4974-9628-E39E65A08ADCQ27023325-32259BFC-B323-413C-9D56-D06ED422606CQ27336487-49DFB85A-26E8-40B3-97EB-19AC3226DA2EQ28077986-690F7924-EB03-4AF5-953C-B05F79CF4FAAQ28080565-285A6C39-FD04-4A6F-82C5-DDD551BD7873Q33578162-6589FA44-AE65-4CE8-8E51-B398555DA7BBQ33749374-5AE39E7B-814F-486E-944A-40398793D698Q33811230-3B25212A-6208-4821-B26B-FF60F0635070Q34149206-FE1C34A6-CFDA-498B-A7D4-AE703A521328Q34422460-A113C4C8-B2DD-4BEC-A51E-06C35F1F1013Q34441749-B4EC5AA1-ABBF-4F2F-A5A7-65BDD6273ADEQ34525560-18AEB684-E04A-46E2-B453-BF56679F72E5Q34617472-B08DFB97-8070-4296-938F-A8F6DB4A49A3Q34661275-90580BB6-E629-4317-A1DB-65A0444E1D4DQ35205665-F93B5B74-D074-4CDE-8068-C38ED683F2C7Q35236178-98656A64-D290-4B11-B18F-8AF51A8752F1Q35532877-27A5CF98-1792-430A-AB42-F3BADD33F80FQ35597418-ED03D307-174C-40C5-8DEC-D3EC1E88E96EQ35690093-5D47A843-B836-4909-9FA8-BF4127D55922Q35824554-A46DAA1F-F28F-4147-A138-F9E31D38B31AQ35875613-5DDF15DC-C13B-4B47-92A7-78CFF1459BF7Q35883152-27058B1F-8378-41F4-9692-F09C061FEFE1Q35995055-7EE6C4EF-DEF5-4E9A-901A-8BD4C7D6100CQ36168777-9CF949D3-A4A6-4379-B1D8-69B0C2045075Q36365384-556ED1E0-8CB6-4290-8664-32CCF2FBC669Q36617382-F521C56D-3896-490B-A165-380C6782A664Q36757779-EC5F55B2-4F2E-4EB9-BBA7-3E46C91DD46AQ36850078-3ECBCADA-7AAC-4038-A204-BB218478DE22Q36864827-A4DB3F9D-FDAC-4A49-BD69-2DBB1E1A5D7EQ36877843-D7926C81-0407-4737-B1B7-DDF1450B1DBCQ36973427-502F1F79-D903-4086-971F-F5B7CD49ADF3
P2860
Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intracoronary delivery of auto ...... hronic ischemic cardiomyopathy
@en
Intracoronary delivery of auto ...... ronic ischemic cardiomyopathy.
@nl
type
label
Intracoronary delivery of auto ...... hronic ischemic cardiomyopathy
@en
Intracoronary delivery of auto ...... ronic ischemic cardiomyopathy.
@nl
prefLabel
Intracoronary delivery of auto ...... hronic ischemic cardiomyopathy
@en
Intracoronary delivery of auto ...... ronic ischemic cardiomyopathy.
@nl
P2093
P2860
P50
P1433
P1476
Intracoronary delivery of auto ...... hronic ischemic cardiomyopathy
@en
P2093
Annarosa Leri
Federico Mosna
Hani Jneid
Jan Kajstura
Marcello Rota
Ornella Rimoldi
Roberto Bolli
Santosh K Sanganalmath
Xian-Liang Tang
P2860
P304
P356
10.1161/CIRCULATIONAHA.112.001075
P407
P577
2013-06-11T00:00:00Z